Gilead licenses hepatitis C drug to Cipla, Ranbaxy, 5 others
September 15, 2014 at 06:06 AM EDT
NEW DELHI/MUMBAI, Sept 15 (Reuters) - U.S. drugmaker Gilead Sciences Inc said on Monday it has licensed its hepatitis C drug to seven companies including Cipla Ltd and Ranbaxy Laboratories Ltd to make it available in 91 developing countries including India.
